Michael Segal

Michael Segal is an accomplished executive in business development and alliance management with extensive experience in the pharmaceutical sector. Currently serving as Executive Director at Sumitomo Pharma America, Inc., since July 2023, Michael drives national and international deals, evaluating opportunities for licensing, collaboration, and acquisitions while aligning business strategies with therapeutic and technology areas. Prior roles at Sunovion Pharmaceuticals included Executive Director and Senior Director of Business Development, emphasizing similar responsibilities in identifying new product opportunities and managing strategic alliances. Michael's earlier career features positions at Organogenesis Inc., Boston Scientific, and clinical roles as a physical therapist, supported by an MBA from Bentley College and a BS in Physical Therapy from Northeastern University.